Ichiro Nakamura, MD

Affiliations: 
Neuropsychiatry Kanazawa University, Kanazawa-shi, Ishikawa-ken, Japan 
Google:
"Ichiro Nakamura"
Bio:

http://dspace.lib.kanazawa-u.ac.jp/dspace/bitstream/2297/8878/1/AN00044397-090-001.pdf

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T0G-3YCF23D-1V&_user=10&_coverDate=11/10/1995&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_searchStrId=14667

Mean distance: 19.07 (cluster 24)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Akihiro U, Matsumoto T, Maenohara Y, et al. (2021) Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib. Clinical Rheumatology
Nakamura I, Maegawa H, Tobe K, et al. (2021) Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Jimi E, Honda H, Nakamura I. (2021) The unique function of p130Cas in regulating the bone metabolism. Pharmacology & Therapeutics. 107965
Nakamura I, Maegawa H, Tobe K, et al. (2021) Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study. Advances in Therapy. 38: 4599-4601
Nakamura I, Maegawa H, Tobe K, et al. (2021) Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. 12: 1765-1768
Tobe K, Maegawa H, Nakamura I, et al. (2021) Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM). Endocrine Journal
Tobe K, Maegawa H, Nakamura I, et al. (2021) Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM). Diabetology International. 12: 181-196
Nakamura I, Maegawa H, Tobe K, et al. (2021) Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Nakamura I, Maegawa H, Tobe K, et al. (2020) Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM). Expert Opinion On Pharmacotherapy. 1-15
Liu L, Nakamura I. (2020) Correction to "Solvation Energy of Ions in Polymers: Effects of Chain Length and Connectivity on Saturated Dipoles near Ions". The Journal of Physical Chemistry. B
See more...